| Literature DB >> 35448119 |
Zul Hadif Abd Aziz1, Haliza Katas1, Marhanis Salihah Omar2, Noraida Mohamed Shah2, Salma Mohamad Yusop3, Mohamad Nasir Shafiee4, Siti Fatimah Mohd Tarmizi3.
Abstract
The development of pharmaceutical dosage forms that are tailored to specific populations according to their preferences and acceptability could improve medication adherence, which could lead to effective pharmacotherapy. This study evaluated the preference for and perceptions of fluid gels as a potential age-appropriate dosage form for older adults with dysphagia. The palatability and swallowability of the developed fluid gels were also assessed to determine the consumer acceptability of this formulation. A cross-sectional survey was conducted through the electronic distribution of a self-administered questionnaire among adults in Malaysia between April and December 2021. A randomized and double-blinded clinical study was conducted to evaluate the palatability and swallowability of the fluid gels in 30 healthy participants. A cross-sectional study involving 673 respondents revealed that the fluid gels were perceived positively by consumers (64.4%), were easily swallowed (50.8%), were safe to be consumed (45.3%), and were suitable as a new pharmaceutical formulation (43.8%). The clinical study shows that moderately thickened fluid gels masked the bitterness of the medication and were easily swallowed. The newly developed fluid gels were also positively perceived by the participants. Taken together, fluid gels have shown great potential as an innovative oral formulation that is suitable for consumption by elderly patients with dysphagia.Entities:
Keywords: adherence; palatability; perception; preference; sheared gel; swallowability
Year: 2022 PMID: 35448119 PMCID: PMC9028045 DOI: 10.3390/gels8040218
Source DB: PubMed Journal: Gels ISSN: 2310-2861
Social demographics of consumers (n = 673).
| Characteristics | n | % |
|---|---|---|
|
| ||
| Male | 324 | 48.1 |
| Female | 349 | 51.9 |
|
| ||
| Malay | 619 | 92.0 |
| Chinese | 31 | 4.6 |
| Indian | 17 | 2.5 |
| Others | 6 | 0.9 |
|
| ||
| 19–30 years old | 280 | 41.6 |
| 31–45 years old | 198 | 29.4 |
| More than 45 years old | 208 | 30.9 |
|
| ||
| Working | ||
| Professional | 412 | 61.2 |
| Self-employed | 25 | 3.7 |
| Not working | ||
| Pensioner | 25 | 3.7 |
| Housewife | 34 | 5.1 |
| Student | 163 | 24.2 |
| Unemployed | 14 | 2.1 |
|
| ||
| Less than RM 1000 (USD 237.30) | 201 | 29.9 |
| RM 1001 (USD 237.54)–RM 3000 (USD 711.91) | 151 | 22.4 |
| RM3001 (USD 712.15)–RM 5000 (USD 1186.52) | 111 | 16.5 |
| More than RM 5001 (USD 1186.76) | 210 | 31.2 |
RM 1 is equal to USD 0.24, converted using Google Finance on 23 March 2022.
Figure 1Preferences of oral liquid formulations for medicines, Section 2 (n = 673).
Mean scores of preferences toward liquid formulations, negative perception toward liquid formulations, and perceived benefits of fluid gels, based on demographic data (n = 673).
| Characteristics | Preferences toward Oral Liquid Formulation | Negative Perception toward Liquid Formulation | Perceived Benefits of Fluid Gels | |||
|---|---|---|---|---|---|---|
| Median ± IQR | Median ± IQR | Median ± IQR | ||||
|
| ||||||
| Male (n = 324) | 71.0 ± 8.0 | 0.253 | 20.0 ± 25.0 | <0.001 ** | 64.0 ± 12.0 | 0.594 |
| Female (n = 349) | 72.0 ± 8.5 | 30.0 ± 35.0 | 64.0 ± 12.0 | |||
|
| ||||||
| 19–30 (n = 280) | 71.5 ± 9.0 | 0.949 | 20.0 ± 25.0 | <0.001 ** | 64.0 ± 10.0 | 0.006 * |
| 31–45 (n = 198) | 71.0 ± 8.0 | 25.0 ± 35.0 | 62.0 ± 12.5 | |||
| More than 45 (n = 208) | 71.0 ± 7.0 | 30.0 ± 35.0 | 66.0 ± 12.0 | |||
|
| ||||||
| Professional (n = 412) | 71.0 ± 8.0 | 0.246 | 25.0 ± 30.0 | <0.001 ** | 64.0 ± 12.0 | 0.024 * |
| Self-employed (n = 25) | 72.0 ± 8.5 | 15.0 ± 35.0 | 66.0 ± 13.0 | |||
| Pensioner (n = 25) | 71.0 ± 6.0 | 35.0 ± 37.5 | 62.0 ± 18.0 | |||
| Housewife (n = 34) | 70.5 ± 9.0 | 27.5 ± 47.5 | 60.0 ± 10.0 | |||
| Student (n = 163) | 71.0 ± 9.0 | 15.0 ± 25.0 | 66.0 ± 12.0 | |||
| Not working (n = 14) | 69.0 ± 7.75 | 25.0 ± 46.3 | 64.0 ± 8.5 | |||
|
| ||||||
| Less than RM 1000 (USD 237.30) (n = 201) | 71.0 ± 9.0 | 0.417 | 20.0 ± 25.0 | <0.001 ** | 66.0 ± 12.0 | 0.153 |
| RM 1001 (USD 237.54) to RM 3000 (USD 711.91) (n = 151) | 71.0 ± 8.0 | 25.0 ± 35.0 | 62.0 ± 10.0 | |||
| RM3001 (USD 712.15) to RM 5000 (USD 1186.52) (n = 111) | 72.0 ± 7.0 | 25.0 ± 35.0 | 64.0 ± 10.0 | |||
| More than RM 5001 (USD 1186.76) (n = 210) | 71.0 ± 8.0 | 30.0 ± 30.0 | 64.0 ± 12.5 | |||
Mann–Whitney U test (2 groups) and Kruskal–Wallis H test (>2 groups): * significant data (p < 0.05); ** significant data (p < 0.001). RM 1 is equal to USD 0.24, converted using Google Finance on 23 March 2022.
Rejection factors with regard to liquid formulations, Section 3 (n = 673).
| Factors That May Influence the Preferences of Oral Fluid Formulations for Medicines | Yes | No | ||
|---|---|---|---|---|
| n | % | n | % | |
| I have problem to understand the instructions for use of medicines because the text is too small. | 184 | 27.3 | 489 | 72.7 |
| I have problem to understand the instructions for use of medicines because the information written too difficult to understand. | 156 | 23.2 | 517 | 76.8 |
| I have problem to understand the instructions for use of medicines because the information on adverse events is distressing. | 169 | 25.1 | 504 | 74.9 |
| I have problem to open my medicines. | 50 | 7.4 | 623 | 92.6 |
| I have problem to identify medicines after it has been removed from its packaging. | 368 | 54.7 | 305 | 45.3 |
| I have problem to take oral fluid medicines because of the taste. | 285 | 42.3 | 388 | 57.7 |
| I have problem to take oral fluid medicines because of their appearance. Example: Sediment or cloudy. | 217 | 32.2 | 456 | 67.8 |
| I have problem to take sweetened or flavored oral fluid medicine. | 87 | 12.9 | 586 | 87.1 |
| I have problem to take oral medicines containing small particles. | 281 | 41.8 | 392 | 58.2 |
| I have problem to swallow solid medicines such as tablets or capsules. | 91 | 13.5 | 582 | 86.5 |
| I have problem to swallow medicines. For examples, choking reflex or cough before swallowing. | 83 | 12.3 | 590 | 87.7 |
| I have problem with the volume of oral fluid medicines. | 161 | 23.9 | 512 | 76.1 |
| I have problem to take frequent oral medicines (more than 2 times a day). | 210 | 31.2 | 463 | 68.8 |
| I have problem to pour fluid medicines. | 59 | 8.8 | 614 | 91.2 |
| I have problem to measure the right dose before taking it. | 154 | 22.9 | 519 | 77.1 |
| I have problem to reconstitute medicines using water. | 247 | 36.7 | 426 | 63.3 |
| I have problem to store oral fluid medicines in a suitable condition after it has been removed from its packaging. | 264 | 39.2 | 409 | 60.8 |
| I have problem to store oral fluid medicines for a long period of time. | 296 | 44 | 377 | 56 |
| I have problem to give oral fluid medicines to young family members (e.g., aged ≤ 12 years old). | 252 | 37.4 | 421 | 62.6 |
| I have problem to give oral fluid medicine to elderly family members (e.g., aged ≥ 65 years old). | 118 | 17.5 | 555 | 82.5 |
Figure 2Perceived benefits and risks of fluid gels, Section 4 (n = 673).
Figure 3Sensory assessment of fluid gel: (a) palatability assessment; and (b) swallowability assessment, where 0 is “None” and 100 is “Strong bitterness” for palatability assessment, and 0 is “Very easy” and 100 is “Very difficult” for swallowability assessment. Fluid gels formulated with different consistency were assigned as samples A and D (thin liquid), B and E (mildly thickened liquid), and C and F (highly thickened liquid).
Figure 4Radar charts for bitterness intensity/ease of swallowing, texture, adhesiveness, slipperiness, appearance, and overall, for fluid gels. Each sensory item is described by its population mean for the 100 mm visual analogue scale (VAS), where 0 is the lowest possible intensity of the stimulus, and 100 is the highest.
Figure 5Overall preference toward fluid gel formulation, where 0 is “Extremely like” and 100 is “Extremely dislike”. Paracetamol (PCM) acts as a control, which is a perception when taking marketed paracetamol suspension/syrup. Fluid gels formulated with different consistency were assigned as samples A and D (thin liquid), B and E (mildly thickened liquid), and C and F (highly thickened liquid).
Formulations of fluid gel samples.
| Ingredients | Formulations | |||||
|---|---|---|---|---|---|---|
| A | B | C | D | E | F | |
| Paracetamol | 5 | 5 | 5 | 0 | 0 | 0 |
| Gellan gum | 0.1 | 0.5 | 1.0 | 0.1 | 0.5 | 1.0 |
| Sodium citrate | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Citric acid | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Methylparaben | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Polyethylene glycol | 20 | 20 | 20 | 20 | 20 | 20 |
| Propylene glycol | 20 | 20 | 20 | 20 | 20 | 20 |
| Xylose | 30 | 30 | 30 | 30 | 30 | 30 |
| Sucralose | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Honey flavor | 2 | 2 | 2 | 2 | 2 | 2 |
| Water, up to | 100 | 100 | 100 | 100 | 100 | 100 |